Norman, D J <br/><br/>
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.  [electronic resource] 

 -  Transplantation  Oct 1988 
 - 523-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-198810000-00011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Child<br/>Child, Preschool<br/>Drug Administration Schedule<br/>Female<br/>Graft Rejection--drug effects<br/>Humans<br/>Immunosuppression Therapy<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Muromonab-CD3<br/>T-Lymphocytes--immunology<br/>Transplantation, Homologous